AstraZeneca Plc

By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...

(Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...

The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...

PARIS, May 9 (Reuters) - European shares fell in early trade on Thursday, halting a sharp three-week rally to multi-year highs, with pharmaceutical stocks trimming recent lofty gains. GlaxoSmithKline and AstraZeneca were both down 0.5 percent. The sector...

(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...

(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) May 6 (Reuters) - The U.N. World Health Organization and the U.S. Centers for Disease Control and Prevention are already working with samples of the new H7N9...

(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...

* Head of diabetes says eyeing broadest portfolio in industry * Aiming to win bigger slice of growing market * Lilly currently No.4 in $40 bln diabetes market * Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt...

Por Ludwig Burger y Frank Siebelt FRANCFORT (Reuters) - Eli Lilly, el cuarto fabricante mundial de medicamentos para la diabetes, buscará tener la variedad más amplia posible de fármacos antidiabéticos con el fin de ganar una mayor porción de ese...

* Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...

By Olivia Oran April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according to two people familiar with the...

The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Telegraph: GDP NUMBERS 'ENCOURAGING' BUT ROAD AHEAD IS NOT EASY - OSBORNE The better-than-...